Reports
Hospital Experiences Responding to the COVID-19 Pandemic: Hospital Pulse Surveys II
Yearend Review of Opioid Use in Medicare Part D in 2020
Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.
USAID Had Limited Control Over COVID-19 Ventilator Donations, Differing_x000D_ From Its Customary Response to Public Health Emergencies
Trend Toward More Expensive Inpatient Hospital Stays in Medicare Emerged Before COVID-19 and Warrants Further Scrutiny
Awardee Challenges in Implementing COVID_19 Vaccination Program
CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.
Update: Top Challenges in Pandemic Relief and Response
Opioid Use in Medicare Part D During the Onset of the COVID-19 Pandemic
Multi-Dipping of Pandemic Response Funds Provided to Tribal Governments
The PRAC and pandemic OIGs identified the possibility of recipients receiving funding from multiple federal programs for the same purpose ( multi-dipping When a recipient receives money from multiple federal sources and uses it for the same purpose, this could be an indication of multi-dipping. ) as a high risk area. This project will focus on funds received by tribal governments, and result in an information brief that identifies programs where multi-dipping When a recipient receives money from multiple federal sources and uses it for the same purpose, this could be an indication of multi-dipping. has occurred in CARES Act programs allowing us to identify and scope the magnitude of the risk.
Assessing CDC’s Adherence to Health and Safety Protocols During COVID-19 Response Efforts at the JFK International Airport’s Quarantine Station
Health Resources and Services Administration's Monitoring of High-Risk COVID-19 Grantees
The Health Resources and Services Administration (HRSA) is the primary Federal agency for improving health care to people who are geographically isolated and economically or medically vulnerable. HRSA should identify and mitigate risks related to awarding grants to health centers to minimize the potential misuse or loss of Federal funds. In spring 2020, HRSA awarded through three programs nearly $2 billion to approximately 1,380 health centers in response to the COVID-19 pandemic. To expedite distribution of this funding, HRSA did not require that health centers apply for grants. Instead, it made funds immediately available to health centers. Health centers had 30 days from the award release date to submit the information that is usually submitted, reviewed, and approved during the grant application process prior to a grantee receiving funding. We will determine whether HRSA had an effective process for identifying and monitoring high-risk health centers that received COVID-19 grants.